Results 1 to 10 of about 4,271,269 (288)

Fuzuloparib with or without apatinib in patients with HER2-negative metastatic breast cancer with germline BRCA1/2 mutations: a cost-utility analysis [PDF]

open access: yesFrontiers in Pharmacology
BackgroundFuzuloparib, a novel PARP inhibitor, has demonstrated efficacy in patients with HER2-negative metastatic breast cancer (MBC) harboring germline BRCA1/2 mutations.
Yitian Lang, Meng Deng, Jie Yang
doaj   +2 more sources

Cost-utility analysis of PCSK9 inhibitors for hypercholesterolemia: a Chinese healthcare perspective [PDF]

open access: yesFrontiers in Pharmacology
ObjectiveTo evaluate the cost-utility of different dosing regimens of PCSK9 inhibitors, added to statin therapy, in patients with hypercholesterolemia or at high cardiovascular risk in China.MethodsA Markov cohort multistate-transition model was ...
Dandan Hu   +6 more
doaj   +2 more sources

Cost Utility Analysis of Multidisciplinary Postacute Care for Stroke: A Prospective Six-Hospital Cohort Study

open access: yesFrontiers in Cardiovascular Medicine, 2022
BackgroundFew studies have compared the optimal duration and intensity of organized multidisciplinary neurological/rehabilitative care delivered in a regional/district hospital with the standard rehabilitative care delivered in the general neurology ...
Yu-Ching Chen   +14 more
doaj   +1 more source

Cost-utility analysis of robotic arm-assisted medial compartment knee arthroplasty: five-year data from a randomized controlled trial

open access: yesBone & Joint Open, 2023
Aims: To perform an incremental cost-utility analysis and assess the impact of differential costs and case volume on the cost-effectiveness of robotic arm-assisted unicompartmental knee arthroplasty (rUKA) compared to manual (mUKA).
Nick. D. Clement   +6 more
doaj   +1 more source

Effectiveness, cost-utility and physiological underpinnings of the FIBROWALK multicomponent therapy in online and outdoor format in individuals with fibromyalgia: Study protocol of a randomized, controlled trial (On&Out study)

open access: yesFrontiers in Physiology, 2022
Introduction: The On&Out study is aimed at assessing the effectiveness, cost-utility and physiological underpinnings of the FIBROWALK multicomponent intervention conducted in two different settings: online (FIBRO-On) or outdoors (FIBRO-Out).
Mayte Serrat   +26 more
doaj   +1 more source

Cost-utility analysis of lurasidone for the first-line treatment of schizophrenia in China

open access: yesFrontiers in Public Health, 2022
ObjectiveTo evaluate the cost-effectiveness of lurasidone compared with olanzapine and risperidone in the first-line treatment of patients with schizophrenia from a Chinese healthcare system perspective.MethodsA Markov model with 6-week cycle was ...
Jia Liu   +5 more
doaj   +1 more source

Preemptive Living-Related Kidney Transplantation Is a Cost-Saving Strategy Compared With Post-dialysis Kidney Transplantation in Thailand

open access: yesFrontiers in Medicine, 2022
BackgroundCompared with other kidney replacement therapies, preemptive kidney transplantation (KT) provides better clinical outcomes, reduces mortality, and improves the quality of life of patients with end-stage kidney disease (ESKD).
Atthaphong Phongphithakchai   +7 more
doaj   +1 more source

Demonstration of high value care to improve oral health of a remote Indigenous community in Australia

open access: yesHealth and Quality of Life Outcomes, 2020
Background The oral health of Indigenous children in remote communities is much worse than other population groups in Australia. Providing and maintaining an oral health service is challenging due to the remoteness of communities, the associated high ...
Sanjeewa Kularatna   +5 more
doaj   +1 more source

Follow the nevus: the cost-utility of monitoring for growth of choroidal nevi [PDF]

open access: yesInternational Journal of Ophthalmology, 2019
AIM: To develop a model to evaluate the cost-utility of choroidal nevi monitoring recommendations with varying clinical risk factors. METHODS: A Markov model was created to evaluate the cost-utility in cost per quality-adjusted life-year ($/QALY) for ...
Alexander S. Barsam   +4 more
doaj   +1 more source

Markov Models for Economic Evaluation in Osteoporosis Treatment

open access: yesMathematics, 2021
Osteoporosis is frequent in elderly people, causing bone fractures and lowering their quality of life. The costs incurred by these fractures constitute a problem for public health. Markov chains were used to carry out an incremental cost-utility analysis
Marta Osca-Guadalajara   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy